Temmler Group's (Specialty Product Portfolio) Overview

  • Status
  • Acquired/​Merged

  • Latest Deal Type
  • M&A

  • Financing Rounds
  • 1

Temmler Group's (Specialty Product Portfolio) General Information

Description

Provider of Central Nervous System (CNS) products. The company provides specialty CNS products that addresses rare disease areas like Myasthenia Gravis, Huntington disease as well as serves as dermatology products for anti-wart treatment.

Contact Information

Ownership Status
Acquired/Merged
Financing Status
Corporate Backed or Acquired
Primary Industry
Pharmaceuticals
Acquirer
Lupin
Primary Office
  • Temmlerstraße 2
  • Marburg
  • Germany

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Temmler Group's (Specialty Product Portfolio) Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA		 Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Temmler Group's (Specialty Product Portfolio)‘s full profile, request access.

Request a free trial

Temmler Group's (Specialty Product Portfolio) Former Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Temmler Group's (Specialty Product Portfolio)‘s full profile, request access.

Request a free trial